Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurogenin3 activates the islet differentiation program while repressing its own expression.

Stuart B Smith1, Hirotaka Watada, Michael S German

  • 1Diabetes Center, Hormone Research Institute, University of California San Francisco, 513 Parnassus Avenue, San Francisco, California 94143-0534, USA.

Molecular Endocrinology (Baltimore, Md.)
|October 25, 2003
PubMed
Summary

Neurogenin3 directs pancreatic endocrine cell differentiation by activating key transcription factor genes. However, it also represses its own promoter, suggesting a complex regulatory feedback loop.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptional and temporal heterogeneity of developing α cells revealed by single-cell RNA sequencing.

Biochemical and biophysical research communications·2025
Same author

An evening chronotype is associated with the incidence and progression of diabetic retinopathy in people with type 2 diabetes mellitus: a cohort study.

Diabetologia·2025
Same author

Effect of tofogliflozin on obesity-related health problems in patients with type 2 diabetes and overweight or obesity-a post-hoc sub-analysis of the UTOPIA study.

Diabetology international·2025
Same author

MyEveryCise: A method for everyday exercise using 'an activity of daily living' as a cue.

Journal of Alzheimer's disease : JAD·2025
Same author

The Beck Depression Inventory-II scores of adults with type 1 diabetes in Japan: Analysis using the Juntendo-Aso Type 1 Diabetes (JAT-1) Cohort.

Journal of diabetes investigation·2025
Same author

Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management.

Drugs·2025

Area of Science:

  • Developmental biology
  • Endocrinology
  • Molecular genetics

Background:

  • Neurogenin3 (NGN3) is a crucial proendocrine factor in pancreatic development.
  • NGN3 dictates progenitor cell fate towards endocrine cell differentiation in the islets of Langerhans.

Purpose of the Study:

  • To elucidate the regulatory mechanisms by which NGN3 controls the promoters of key endocrine differentiation genes.
  • To investigate NGN3's interaction with the promoters of nkx2.2, PAX4, and its own gene, NEUROG3.

Main Methods:

  • Analysis of promoter activity through E box binding site interactions.
  • Assessing transcriptional activation and repression by NGN3 on target gene promoters.
  • Investigating the role of NGN3's DNA-binding and transcriptional activation domains.

Related Experiment Videos

Main Results:

  • NGN3 activates transcription of nkx2.2 and PAX4 via their E box elements.
  • NGN3 strongly represses the NEUROG3 promoter, potentially through competitive inhibition or induction of repressors.
  • The DNA-binding domain of NGN3 is sufficient for some repression, while the activation domain enhances it.

Conclusions:

  • NGN3 orchestrates islet cell differentiation by activating essential transcription factor genes.
  • NGN3 employs a feedback mechanism by repressing its own promoter activity.
  • This dual action ensures precise regulation of endocrine cell development.